
CAT to rule on whether NHS ‘pay for delay’ case against Lundbeck and other pharmaceuticals companies is time-barred
Peters & Peters has recently been instructed to act for the NHS in long-running litigation against the Danish pharmaceutical company Lundbeck and several others. The claims arise from the European Commission’s 2013 decision that Lundbeck and the other defendants infringed European competition law by entering into ‘pay for delay’ agreements under which generic producers and […]